<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03391284</url>
  </required_header>
  <id_info>
    <org_study_id>SCRIPPS-WHR-ACET-01</org_study_id>
    <nct_id>NCT03391284</nct_id>
  </id_info>
  <brief_title>Oral vs Intravenous Acetominophen for Postoperative Pain in Minimally Invasive Gynecologic Surgery</brief_title>
  <official_title>Preemptive Oral vs Intravenous Acetominophen for Postoperative Pain in Minimally Invasive Gynecologic Surgery: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Scripps Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Scripps Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Postoperative pain will be equivalent in patients receiving preemptive oral&#xD;
      acetaminophen as compared to patients receiving preemptive intravenous acetaminophen&#xD;
      following minimally invasive benign gynecologic surgery.&#xD;
&#xD;
      Primary outcome:&#xD;
&#xD;
      â€¢ Difference in postoperative pain comparing preemptive use of PO versus IV acetaminophen&#xD;
&#xD;
      o Mean Visual analog Scale (VAS) scores will be compared between the intervention group (PO&#xD;
      acetaminophen) and the control group (IV acetaminophen).&#xD;
&#xD;
      Secondary outcomes:&#xD;
&#xD;
        -  Difference in postoperative analgesic use between groups&#xD;
&#xD;
           o Narcotics, NSAIDs&#xD;
&#xD;
        -  Difference in postoperative N/V between groups&#xD;
&#xD;
           o Patient rated measure - none, mild, moderate, severe&#xD;
&#xD;
        -  Cost comparison between drugs&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: Postoperative pain will be equivalent in patients receiving preemptive oral&#xD;
      acetaminophen as compared to patients receiving preemptive intravenous acetaminophen&#xD;
      following minimally invasive benign gynecologic surgery.&#xD;
&#xD;
      Importance/significance: Adequate control of postoperative pain is important for patient&#xD;
      satisfaction, adequate healing, and optimizing length of stay. The idea of preemptive&#xD;
      analgesia (giving an analgesic prior to first skin incision to prevent sensitization of nerve&#xD;
      pathways from the trauma of surgery) has been shown in many studies to improve postoperative&#xD;
      pain. Intravenous acetaminophen has been found to be an effective agent when given&#xD;
      preemptively, and many surgeons have adopted this practice. Unfortunately, the IV formulation&#xD;
      of acetaminophen, unlike the oral formulation, is expensive as it is a relatively new drug.&#xD;
      There are other oral analgesics (i.e. Celebrex) that have been found to be efficacious for&#xD;
      postoperative pain control when given preemptively. There are no studies in gynecologic&#xD;
      surgery, however, comparing the effectiveness of PO acetaminophen with IV acetaminophen.&#xD;
      Given that PO acetaminophen is significantly cheaper than the IV formulation, this could&#xD;
      result in cost savings for hospital systems while maintaining adequate patient comfort and&#xD;
      satisfaction.&#xD;
&#xD;
      Primary outcome:&#xD;
&#xD;
        1. Difference in postoperative pain comparing preemptive use of PO versus IV acetaminophen&#xD;
&#xD;
        2. Mean VAS scores will be compared between the intervention group (PO acetaminophen) and&#xD;
           the control group (IV acetaminophen).&#xD;
&#xD;
      Secondary outcomes:&#xD;
&#xD;
        1. Difference in postoperative analgesic use between groups - Narcotics, NSAIDs&#xD;
&#xD;
        2. Difference in postoperative N/V between groups&#xD;
&#xD;
        3. Patient rated measure - none, mild, moderate, severe&#xD;
&#xD;
        4. Cost comparison between drugs&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      Patients scheduled to undergo minimally invasive benign gynecologic surgery will be&#xD;
      randomized to one of two groups:&#xD;
&#xD;
      Group 1: acetaminophen 1 gram PO 30min before surgery, then saline placebo IV after&#xD;
      anesthesia induction but before skin incision&#xD;
&#xD;
      Group 2: receives placebo pill PO 30min before surgery, then acetaminophen 1 gram IV after&#xD;
      anesthesia induction but before skin incision&#xD;
&#xD;
      Primary outcome: After surgery, postoperative pain measured at various time points by blinded&#xD;
      investigator&#xD;
&#xD;
      2 hours postop, 4 hours postop, 24 hours postop&#xD;
&#xD;
      Secondary outcomes:&#xD;
&#xD;
        1. Evaluate N/V - self-rated as none, mild, moderate, severe&#xD;
&#xD;
        2. Document amount of analgesic use (narcotic, NSAIDs) during hospital course&#xD;
&#xD;
        3. Compute cost comparison between medications&#xD;
&#xD;
      Demographics to collect:&#xD;
&#xD;
      Age, parity, BMI, procedure indication, pathology including uterine weight, procedure length&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain - VAS</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain - VAS</measure>
    <time_frame>4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain - VAS</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Post-operative Pain</condition>
  <arm_group>
    <arm_group_label>Oral</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1000 mg acetominophen oral</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravenous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 mg acetominophen intravenous</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetominophen</intervention_name>
    <description>INTRAVENOUS</description>
    <arm_group_label>Intravenous</arm_group_label>
    <arm_group_label>Oral</arm_group_label>
    <other_name>Ofirmev</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>ORAL</description>
    <arm_group_label>Intravenous</arm_group_label>
    <arm_group_label>Oral</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years of age or older scheduled to undergo robotic-assisted laparoscopic&#xD;
             hysterectomy for benign conditions.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known or suspected malignancy,&#xD;
&#xD;
          -  Active liver/renal disease,&#xD;
&#xD;
          -  Chronic alcohol use/alcoholism,&#xD;
&#xD;
          -  Allergy to acetaminophen,&#xD;
&#xD;
          -  Conversion to laparotomy,&#xD;
&#xD;
          -  hx gastroparesis,&#xD;
&#xD;
          -  Poorly controlled insulin dependent diabetes or gastric bypass surgery,&#xD;
&#xD;
          -  Regular/recent (past 6 months) narcotic use,&#xD;
&#xD;
          -  Inability to swallow pills.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruce Kahn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scripps</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Scripps Clinic</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Clininc Dept of Ob/Gyn</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <study_first_submitted>January 9, 2016</study_first_submitted>
  <study_first_submitted_qc>December 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2018</study_first_posted>
  <last_update_submitted>December 29, 2017</last_update_submitted>
  <last_update_submitted_qc>December 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Scripps Health</investigator_affiliation>
    <investigator_full_name>Bruce Kahn</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

